WAT Medical Marks Its 8th Consecutive Year of Charitable Giving, Expanding Support for the Veteran Community
VANCOUVER, BC, Nov. 9, 2026 /PRNewswire/ -- WAT Medical Enterprise Ltd. proudly announces its eighth consecutive year of charitable giving. This year, the company continues its annual financial contribution to The American Legion and expands its support for the veteran community through medical device donations to Semper Fi & America's Fund, special purchasing discounts for military personnel, and investment in clinical research.
WAT Medical develops wearable technologies to address common yet challenging health conditions. Its HeadaTerm 2 device is FDA-cleared for the prevention of episodic migraine in adults, offering a portable, drug-free approach to migraine prevention and treatment. The company's mission is to make practical and affordable health solutions more accessible to people who need them.
As part of its annual commitment, WAT Medical continues to donate US$1 for every HeadaTerm 2 device sold to The American Legion. Now in its eighth consecutive year, this initiative reflects the company's long-standing dedication to supporting veterans and organizations that serve them.
Beyond financial contributions, WAT Medical also participated in an in-kind donation initiative with Semper Fi & America's Fund, providing HeadaTerm 2 devices to support veterans and service members experiencing migraine-related challenges. In recognition of its contribution, WAT Medical received a certificate of appreciation from the organization. This initiative allows the company to extend its mission beyond financial support by putting practical health technology directly into the hands of individuals who may benefit from it.
WAT Medical's support for the military community also extends to everyday purchasing opportunities. The company offers additional discounts to veterans and active-duty military personnel, helping make its products more affordable. Over time, WAT has received positive feedback from military community members who have used its devices to address their health concerns, reinforcing the value of accessible, non-pharmaceutical health solutions.
The company's commitment to giving back also includes advancing medical research. Through Mitacs, WAT Medical has introduced a clinical research initiative for HeadaTerm 2, supporting further exploration of its clinical applications in migraine prevention. The company views investment in medical research as another meaningful way to contribute to healthcare progress and benefit patients beyond its immediate customer community.
"Supporting veterans and people facing health challenges is closely connected to our founding mission," said the founder of WAT Medical. "We started this company to provide practical and affordable health solutions to those who need them. Whether through financial donations, product contributions, special purchasing support, or clinical research, we hope to make a meaningful difference in people's lives."
Since 2018, charitable giving has been an integral part of WAT Medical's corporate social responsibility efforts. The company has supported organizations including the Red Cross, the EDS community, and MD Anderson Cancer Center. Through regular financial contributions, in-kind donations, and partnerships with nonprofit organizations, WAT Medical will continue to uphold its commitment to giving back and creating a positive impact in communities worldwide.
References
SOURCE WAT Medical Enterprise Ltd.
Share this article